Mesoblast | MSB - Current Assets


Mesoblast reported $202.48M in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Avita Medical AUD 35.49M 760K Dec/2025
Clinuvel Pharmaceuticals AUD 261.38M 1.59M Dec/2025
Cochlear AUD 1.37B 43.9M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Pacific Edge NZD 29.58M 1.24M Dec/2025
Paradigm Biopharmaceuticals AUD 21.67M 2.46M Dec/2025
PYC Therapeutics AUD 153.74M 23.79M Dec/2025
Ramsay Health Care AUD 3.56B 480.3M Dec/2025
Sonic Healthcare AUD 2.3B 52.76M Dec/2024
Starpharma Holdings AUD 24.24M 1.68M Dec/2025
Telix Pharmaceuticals AUD 330.28M 67.73M Dec/2025